Minnesota SF 1615: Biopharmaceutical manufacturing facility sales exemption and refund eligibility authorization

Status: Chief author added Hoffman (as of 2013-05-02)

State: Minnesota · Session: 2013-2014 · Bill: SF 1615

Subjects: Drugs and Medicine, Economic Development, Health and Health Department, Taxation-Sales and Use

Sponsors: Hoffman, Eaton, Skoe

View Minnesota SF 1615 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.